000			01511 a2200433 4500
005			20250516082225.0
264		0	_c20121017
008			201210s 0 0 eng d
022			_a1573-2509
024	7		_a10.1016/j.schres.2012.02.021 _2doi
040			_aNLM _beng _cNLM
100	1		_aWang, Man
245	0	0	_aMetformin for treatment of antipsychotic-induced weight gain: a randomized, placebo-controlled study. _h[electronic resource]
260			_bSchizophrenia research _cJun 2012
300			_a54-7 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAntipsychotic Agents _xadverse effects
650	0	4	_aBlood Glucose _xdrug effects
650	0	4	_aBody Mass Index
650	0	4	_aBody Weight _xdrug effects
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aHypoglycemic Agents _xtherapeutic use
650	0	4	_aInsulin Resistance
650	0	4	_aMale
650	0	4	_aMetformin _xtherapeutic use
650	0	4	_aOverweight _xchemically induced
650	0	4	_aSchizophrenia _xdrug therapy
650	0	4	_aWeight Gain _xdrug effects
700	1		_aTong, Jian-hua
700	1		_aZhu, Gang
700	1		_aLiang, Guang-ming
700	1		_aYan, Hong-fei
700	1		_aWang, Xiu-zhen
773	0		_tSchizophrenia research _gvol. 138 _gno. 1 _gp. 54-7
856	4	0	_uhttps://doi.org/10.1016/j.schres.2012.02.021 _zAvailable from publisher's website
999			_c21603810 _d21603810